{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:44:18Z","timestamp":1790797458624,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T00:00:00Z","timestamp":1603152000000},"content-version":"vor","delay-in-days":2029,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["HL079584"],"award-info":[{"award-number":["HL079584"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["HL080499"],"award-info":[{"award-number":["HL080499"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["HL074399"],"award-info":[{"award-number":["HL074399"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["HL089920"],"award-info":[{"award-number":["HL089920"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["HL096032"],"award-info":[{"award-number":["HL096032"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["HL105157"],"award-info":[{"award-number":["HL105157"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["HL110488"],"award-info":[{"award-number":["HL110488"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["AG047776"],"award-info":[{"award-number":["AG047776"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1074\/jbc.m114.631580","type":"journal-article","created":{"date-parts":[[2015,2,14]],"date-time":"2015-02-14T00:58:17Z","timestamp":1423875497000},"page":"9101-9110","source":"Crossref","is-referenced-by-count":93,"title":["Gefitinib-mediated Reactive Oxygen Specie (ROS) Instigates Mitochondrial Dysfunction and Drug Resistance in Lung Cancer Cells"],"prefix":"10.1016","volume":"290","author":[{"given":"Imoh S.","family":"Okon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen A.","family":"Coughlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hui","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M114.631580_bib1","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.cell.2012.02.063","article-title":"Oncogenic mutations counteract intrinsic disorder in the EGFR kinase and promote receptor dimerization","volume":"149","author":"Shan","year":"2012","journal-title":"Cell"},{"key":"10.1074\/jbc.M114.631580_bib2","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.cell.2006.05.013","article-title":"An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor","volume":"125","author":"Zhang","year":"2006","journal-title":"Cell"},{"key":"10.1074\/jbc.M114.631580_bib3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/35052073","article-title":"Untangling the ErbB signaling network","volume":"2","author":"Yarden","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol"},{"key":"10.1074\/jbc.M114.631580_bib4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrc1360","article-title":"The discovery of receptor tyrosine kinases: targets for cancer therapy","volume":"4","author":"Gschwind","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1074\/jbc.M114.631580_bib5","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1056\/NEJMoa044238","article-title":"EGFR mutation and resistance of non-small-cell lung cancer to gefitinib","volume":"352","author":"Kobayashi","year":"2005","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.M114.631580_bib6","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1038\/onc.2009.198","article-title":"Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors","volume":"28","author":"Gazdar","year":"2009","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M114.631580_bib7","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMoa040938","article-title":"Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib","volume":"350","author":"Lynch","year":"2004","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.M114.631580_bib8","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1158\/0008-5472.226.65.1","article-title":"Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung","volume":"65","author":"Amann","year":"2005","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.M114.631580_bib9","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1126\/science.1101637","article-title":"Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways","volume":"305","author":"Sordella","year":"2004","journal-title":"Science"},{"key":"10.1074\/jbc.M114.631580_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040316","article-title":"Gefitinib-induced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimetics","volume":"4","author":"Cragg","year":"2007","journal-title":"PLoS Med"},{"key":"10.1074\/jbc.M114.631580_bib11","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1371\/journal.pmed.0020073","article-title":"Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain","volume":"2","author":"Pao","year":"2005","journal-title":"PLoS Med"},{"key":"10.1074\/jbc.M114.631580_bib12","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1172\/JCI36183","article-title":"Biomarkers for epithelial-mesenchymal transitions","volume":"119","author":"Zeisberg","year":"2009","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.M114.631580_bib13","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1158\/0008-5472.CAN-08-2819","article-title":"Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer","volume":"69","author":"Arumugam","year":"2009","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.M114.631580_bib14","first-page":"5190","article-title":"Loss of epithelial markers and acquisition of vimentin expression in adriamycin- and vinblastine-resistant human breast cancer cell lines","volume":"52","author":"Sommers","year":"1992","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.M114.631580_bib15","first-page":"75","article-title":"Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic","volume":"1796","author":"Voulgari","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.M114.631580_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF01753886","article-title":"Oncogene-induced basement membrane invasiveness in human mammary epithelial cells","volume":"12","author":"Thompson","year":"1994","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1074\/jbc.M114.631580_bib17","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.devcel.2008.05.009","article-title":"Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis","volume":"14","author":"Yang","year":"2008","journal-title":"Dev. Cell"},{"key":"10.1074\/jbc.M114.631580_bib18","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/ncb1355","article-title":"Vimentin function in lymphocyte adhesion and transcellular migration","volume":"8","author":"Nieminen","year":"2006","journal-title":"Nat. Cell Biol"},{"key":"10.1074\/jbc.M114.631580_bib19","first-page":"186","article-title":"[Role of vimentin in cell migration.]","volume":"44","author":"Chernoivanenko","year":"2013","journal-title":"Ontogenez"},{"key":"10.1074\/jbc.M114.631580_bib20","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1096\/fj.09-151639","article-title":"Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition","volume":"24","author":"Mendez","year":"2010","journal-title":"FASEB J"},{"key":"10.1074\/jbc.M114.631580_bib21","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.yexcr.2007.03.040","article-title":"Novel functions of vimentin in cell adhesion, migration, and signaling","volume":"313","author":"Ivaska","year":"2007","journal-title":"Exp. Cell Res"},{"key":"10.1074\/jbc.M114.631580_bib22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1600-0897.2009.00803.x","article-title":"RCAS1, MT, and vimentin as potential markers of tumor microenvironment remodeling","volume":"63","author":"Dutsch-Wicherek","year":"2010","journal-title":"Am. J. Reprod. Immunol"},{"key":"10.1074\/jbc.M114.631580_bib23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/mp.52.4.189","article-title":"CD44 cell adhesion molecules","volume":"52","author":"Goodison","year":"1999","journal-title":"Mol. Pathol"},{"key":"10.1074\/jbc.M114.631580_bib24","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1083\/jcb.200302098","article-title":"The liberation of CD44","volume":"161","author":"Cichy","year":"2003","journal-title":"J. Cell Biol"},{"key":"10.1074\/jbc.M114.631580_bib25","doi-asserted-by":"crossref","first-page":"27913","DOI":"10.1074\/jbc.272.44.27913","article-title":"Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation","volume":"272","author":"Bourguignon","year":"1997","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M114.631580_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrm1004","article-title":"CD44: from adhesion molecules to signaling regulators","volume":"4","author":"Ponta","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol"},{"key":"10.1074\/jbc.M114.631580_bib27","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nrc3023","article-title":"CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?","volume":"11","author":"Z\u00f6ller","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1074\/jbc.M114.631580_bib28","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1091\/mbc.e11-08-0719","article-title":"The cytoskeleton mechanisms of cell-cell junction formation in endothelial cells","volume":"23","author":"Hoelzle","year":"2012","journal-title":"Mol. Biol. Cell"},{"key":"10.1074\/jbc.M114.631580_bib29","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1083\/jcb.201110135","article-title":"Fascin promotes filopodia formation independent of its role in actin bundling","volume":"197","author":"Zanet","year":"2012","journal-title":"J. Cell Biol"},{"key":"10.1074\/jbc.M114.631580_bib30","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ceb.2004.07.009","article-title":"Roles of fascin in cell adhesion and motility","volume":"16","author":"Adams","year":"2004","journal-title":"Curr. Opin. Cell Biol"},{"key":"10.1074\/jbc.M114.631580_bib31","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-2407-12-32","article-title":"Fascin overexpression promotes neoplastic progression in oral squamous cell carcinoma","volume":"12","author":"Alam","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1074\/jbc.M114.631580_bib32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/jclinpath-2011-200425","article-title":"Fascin expression in endocervical neoplasia: correlation with tumor morphology and growth pattern","volume":"65","author":"Stewart","year":"2012","journal-title":"J. Clin. Pathol"},{"key":"10.1074\/jbc.M114.631580_bib33","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.biocel.2005.05.004","article-title":"Roles of fascin in human carcinoma motility and signaling: prospects for a novel biomarker","volume":"37","author":"Hashimoto","year":"2005","journal-title":"Int. J. Biochem. Cell Biol"},{"key":"10.1074\/jbc.M114.631580_bib34","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/nrm1438","article-title":"Intermediate filaments mediate cytoskeleton crosstalk","volume":"5","author":"Chang","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol"},{"key":"10.1074\/jbc.M114.631580_bib35","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/jnr.20293","article-title":"Pyruvate dehydrogenase complex: metabolic link to ischemic brain injury and target of oxidative stress","volume":"79","author":"Martin","year":"2005","journal-title":"J. Neurosci. Res"},{"key":"10.1074\/jbc.M114.631580_bib36","first-page":"2513","article-title":"Epithelial-mesenchymal transition in EGFR-TKI acquired resistant lung adenocarcinoma","volume":"30","author":"Uramoto","year":"2010","journal-title":"Anticancer Res"},{"key":"10.1074\/jbc.M114.631580_bib37","doi-asserted-by":"crossref","first-page":"221ra15","DOI":"10.1126\/scitranslmed.3007653","article-title":"Antioxidants accelerate lung cancer progression in mice","volume":"6","author":"Sayin","year":"2014","journal-title":"Sci. Transl. Med"},{"key":"10.1074\/jbc.M114.631580_bib38","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/10408690490468489","article-title":"Antioxidants and prevention of chronic disease","volume":"44","author":"Willcox","year":"2004","journal-title":"Crit. Rev. Food Sci. Nutr"},{"key":"10.1074\/jbc.M114.631580_bib39","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S1097-2765(02)00520-8","article-title":"C-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability","volume":"9","author":"Vafa","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1074\/jbc.M114.631580_bib40","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1126\/science.275.5306.1649","article-title":"Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts","volume":"275","author":"Irani","year":"1997","journal-title":"Science"},{"key":"10.1074\/jbc.M114.631580_bib41","doi-asserted-by":"crossref","first-page":"27393","DOI":"10.1016\/S0021-9258(19)61523-1","article-title":"Oxidative stress promotes specific protein damage in Saccharomyces cerevisiae","volume":"275","author":"Cabiscol","year":"2000","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M114.631580_bib42","doi-asserted-by":"crossref","first-page":"H1621","DOI":"10.1152\/ajpheart.01008.2007","article-title":"Deficiency of mitogen-activated protein kinase phosphatase-1 results in iNOS-mediated hypotension in response to low-dose endotoxin","volume":"294","author":"Calvert","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol"},{"key":"10.1074\/jbc.M114.631580_bib43","first-page":"1","article-title":"Reactive oxygen species and drug resistance in cancer chemotherapy","volume":"1","author":"Chen","year":"2014","journal-title":"Austin J. Clin. Pathol"},{"key":"10.1074\/jbc.M114.631580_bib44","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature10167","article-title":"Selective killing of cancer cells by a small molecule targeting the stress response to ROS","volume":"475","author":"Raj","year":"2011","journal-title":"Nature"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925819819993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925819819993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M114.631580","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T15:45:11Z","timestamp":1691250311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925819819993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":44,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0021925819819993"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m114.631580","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}